eszopiclone

Generic: eszopiclone

Labeler: nucarepharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name eszopiclone
Generic Name eszopiclone
Labeler nucarepharmaceuticals, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

eszopiclone 3 mg/1

Manufacturer
NuCarePharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 68071-3376
Product ID 68071-3376_1ce8fd7d-c659-0b3f-e063-6394a90ae539
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA202929
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2014-04-25

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 680713376
Hyphenated Format 68071-3376

Supplemental Identifiers

RxCUI
485465
UPC
0368071337631
UNII
UZX80K71OE

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eszopiclone (source: ndc)
Generic Name eszopiclone (source: ndc)
Application Number ANDA202929 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 3 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED in 1 BOTTLE (68071-3376-3)
source: ndc

Packages (1)

Ingredients (1)

eszopiclone (3 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1ce8fd7d-c659-0b3f-e063-6394a90ae539", "openfda": {"upc": ["0368071337631"], "unii": ["UZX80K71OE"], "rxcui": ["485465"], "spl_set_id": ["53fcee89-027a-13e5-e054-00144ff8d46c"], "manufacturer_name": ["NuCarePharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (68071-3376-3)", "package_ndc": "68071-3376-3", "marketing_start_date": "20170710"}], "brand_name": "Eszopiclone", "product_id": "68071-3376_1ce8fd7d-c659-0b3f-e063-6394a90ae539", "dosage_form": "TABLET, FILM COATED", "product_ndc": "68071-3376", "dea_schedule": "CIV", "generic_name": "Eszopiclone", "labeler_name": "NuCarePharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eszopiclone", "active_ingredients": [{"name": "ESZOPICLONE", "strength": "3 mg/1"}], "application_number": "ANDA202929", "marketing_category": "ANDA", "marketing_start_date": "20140425", "listing_expiration_date": "20261231"}